{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:46:50Z","timestamp":1782805610479,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"DOI":"10.1038\/s41423-026-01430-x","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T06:10:29Z","timestamp":1779948629000},"page":"806-822","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Macrophage USP9X attenuates colitis by restricting oncostatin M production via K27-linked deubiquitination of STAT1"],"prefix":"10.1038","volume":"23","author":[{"given":"Tao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanyi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadi","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangmao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0326-543X","authenticated-orcid":false,"given":"Zhanju","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0147-7826","authenticated-orcid":false,"given":"Hailong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"1430_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/s41586-022-05308-6","volume":"611","author":"LM Sanmarco","year":"2022","unstructured":"Sanmarco LM, Chao C-C, Wang Y-C, Kenison JE, Li Z, Rone JM, et al. Identification of environmental factors that promote intestinal inflammation. Nature. 2022;611:801\u20139.","journal-title":"Nature"},{"key":"1430_CR2","doi-asserted-by":"crossref","unstructured":"Iliev ID, Ananthakrishnan AN, Guo C-J. Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities. Nat Rev Microbiol 2025;23:509\u2013524.","DOI":"10.1038\/s41579-025-01163-0"},{"key":"1430_CR3","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41588-023-01384-0","volume":"55","author":"Z Liu","year":"2023","unstructured":"Liu Z, Liu R, Gao H, Jung S, Gao X, Sun R, et al. Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries. Nat Genet. 2023;55:796\u2013806.","journal-title":"Nat Genet"},{"key":"1430_CR4","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1056\/NEJMra1909094","volume":"385","author":"G Schett","year":"2021","unstructured":"Schett G, McInnes IB, Neurath MF. Reframing immune-mediated inflammatory diseases through signature cytokine hubs. N Engl J Med. 2021;385:628\u201339.","journal-title":"N Engl J Med"},{"key":"1430_CR5","doi-asserted-by":"crossref","unstructured":"Neurath MF, Artis D, Becker C The intestinal barrier: a pivotal role in health, inflammation, and cancer. Lancet Gastroenterol Hepatol 2025.","DOI":"10.1016\/S2468-1253(24)00390-X"},{"key":"1430_CR6","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/nm.4430","volume":"23","author":"AM Mowat","year":"2017","unstructured":"Mowat AM, Scott CL, Bain CC. Barrier-tissue macrophages: functional adaptation to environmental challenges. Nat Med. 2017;23:1258\u201370.","journal-title":"Nat Med"},{"key":"1430_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","volume":"8","author":"S Chen","year":"2023","unstructured":"Chen S, Saeed AFUH, Liu Q, Jiang Q, Xu H, Xiao GG, et al. Macrophages in immunoregulation and therapeutics. Sig Transduct Target Ther. 2023;8:207.","journal-title":"Sig Transduct Target Ther"},{"key":"1430_CR8","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41575-023-00769-0","volume":"20","author":"LM Hegarty","year":"2023","unstructured":"Hegarty LM, Jones G-R, Bain CC. Macrophages in intestinal homeostasis and inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2023;20:538\u201353.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1430_CR9","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41575-019-0172-4","volume":"16","author":"YR Na","year":"2019","unstructured":"Na YR, Stakenborg M, Seok SH, Matteoli G. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat Rev Gastroenterol Hepatol. 2019;16:531\u201343.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1430_CR10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211846","volume":"219","author":"D Domanska","year":"2022","unstructured":"Domanska D, Majid U, Karlsen VT, Merok MA, Beitnes A-CR, Yaqub S, et al. Single-cell transcriptomic analysis of human colonic macrophages reveals niche-specific subsets. J Exp Med. 2022;219:e20211846.","journal-title":"J Exp Med"},{"key":"1430_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.gpb.2020.11.004","volume":"20","author":"F Ji","year":"2022","unstructured":"Ji F, Zhou M, Zhu H, Jiang Z, Li Q, Ouyang X, et al. Integrative proteomic analysis of multiple posttranslational modifications in inflammatory response. Genomics Proteom Bioinforma. 2022;20:163\u201376.","journal-title":"Genomics Proteom Bioinforma"},{"key":"1430_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41584-022-00778-4","volume":"18","author":"DB Beck","year":"2022","unstructured":"Beck DB, Werner A, Kastner DL, Aksentijevich I. Disorders of ubiquitylation: unchained inflammation. Nat Rev Rheumatol. 2022;18:435\u201347.","journal-title":"Nat Rev Rheumatol"},{"key":"1430_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.736","volume":"5","author":"Y Liao","year":"2024","unstructured":"Liao Y, Zhang W, Liu Y, Zhu C, Zou Z. The role of ubiquitination in health and disease. MedComm (2020). 2024;5:e736.","journal-title":"MedComm (2020)"},{"key":"1430_CR14","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.apsb.2024.12.012","volume":"15","author":"X Liu","year":"2025","unstructured":"Liu X, Fang Y, Huang M, Tu S, Zheng B, Yuan H, et al. Deubiquitinase JOSD2 alleviates colitis by inhibiting inflammation via deubiquitination of IMPDH2 in macrophages. Acta Pharm Sin B. 2025;15:1039\u201355.","journal-title":"Acta Pharm Sin B"},{"key":"1430_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411320","volume":"12","author":"W Xu","year":"2025","unstructured":"Xu W, Hua Z, Wang Y, Tang W, Ge W, Chen Y, et al. Redox-induced stabilization of AMBRA1 by USP7 promotes intestinal oxidative stress and colitis through antagonizing DUB3-mediated NRF2 deubiquitination. Adv Sci. 2025;12:2411320.","journal-title":"Adv Sci"},{"key":"1430_CR16","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/s41418-023-01148-7","volume":"30","author":"X Liu","year":"2023","unstructured":"Liu X, Fang Y, Lv X, Hu C, Chen G, Zhang L, et al. Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3. Cell Death Differ. 2023;30:1457\u201371.","journal-title":"Cell Death Differ"},{"key":"1430_CR17","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1172\/JCI97325","volume":"128","author":"OM Khan","year":"2018","unstructured":"Khan OM, Carvalho J, Spencer-Dene B, Mitter R, Frith D, Snijders AP, et al. The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer. J Clin Investig. 2018;128:1326\u201337.","journal-title":"J Clin Investig"},{"key":"1430_CR18","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1084\/jem.20140860","volume":"211","author":"E Naik","year":"2014","unstructured":"Naik E, Webster JD, DeVoss J, Liu J, Suriben R, Dixit VM. Regulation of proximal T-cell receptor signaling and tolerance induction by deubiquitinase Usp9X. J Exp Med. 2014;211:1947\u201355.","journal-title":"J Exp Med"},{"key":"1430_CR19","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154217","volume":"132","author":"B Wang","year":"2022","unstructured":"Wang B, Tang X, Yao L, Wang Y, Chen Z, Li M, et al. Disruption of USP9X in macrophages promotes foam cell formation and atherosclerosis. J Clin Investig. 2022;132:e154217.","journal-title":"J Clin Investig"},{"key":"1430_CR20","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/mi.2017.22","volume":"10","author":"T Joeris","year":"2017","unstructured":"Joeris T, M\u00fcller-Luda K, Agace WW, Mowat AM. Diversity and functions of intestinal mononuclear phagocytes. Mucosal Immunol. 2017;10:845\u201364.","journal-title":"Mucosal Immunol"},{"key":"1430_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.immuni.2012.12.001","volume":"38","author":"S Yona","year":"2013","unstructured":"Yona S, Kim K-W, Wolf Y, Mildner A, Varol D, Breker M, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity. 2013;38:79\u201391.","journal-title":"Immunity"},{"key":"1430_CR22","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41590-024-01804-1","volume":"25","author":"N Fortelny","year":"2024","unstructured":"Fortelny N, Farlik M, Fife V, Gorki A-D, Lassnig C, Maurer B, et al. JAK-STAT signaling maintains homeostasis in T cells and macrophages. Nat Immunol. 2024;25:847\u201359.","journal-title":"Nat Immunol"},{"key":"1430_CR23","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","volume":"185","author":"RL Philips","year":"2022","unstructured":"Philips RL, Wang Y, Cheon H, Kanno Y, Gadina M, Sartorelli V, et al. The JAK-STAT pathway at 30: much learned, much more to do. Cell. 2022;185:3857\u201376.","journal-title":"Cell"},{"key":"1430_CR24","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nm.4307","volume":"23","author":"NR West","year":"2017","unstructured":"West NR, Hegazy AN, Owens BMJ, Bullers SJ, Linggi B, Buonocore S, et al. Oncostatin M drives intestinal inflammation in mice and its abundance predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. Nat Med. 2017;23:579\u201389.","journal-title":"Nat Med"},{"key":"1430_CR25","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1093\/ibd\/izab032","volume":"27","author":"S Verstockt","year":"2021","unstructured":"Verstockt S, Verstockt B, Machiels K, Vancamelbeke M, Ferrante M, Cleynen I, et al. Oncostatin M is a biomarker of diagnosis, worse disease prognosis, and therapeutic nonresponse in inflammatory bowel disease. Inflamm Bowel Dis. 2021;27:1564\u201375.","journal-title":"Inflamm Bowel Dis"},{"key":"1430_CR26","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/s41590-025-02149-z","volume":"26","author":"R Cineus","year":"2025","unstructured":"Cineus R, Luo Y, Saliutina M, Manna S, Cancino CA, Velasco Bl\u00e1zquez L, et al. The IL-22\u2013oncostatin M axis promotes intestinal inflammation and tumorigenesis. Nat Immunol. 2025;26:837\u201353.","journal-title":"Nat Immunol"},{"key":"1430_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42386-0","volume":"14","author":"LM Riedmayr","year":"2023","unstructured":"Riedmayr LM, Hinrichsmeyer KS, Thalhammer SB, Mittas DM, Karguth N, Otify DY, et al. mRNA trans-splicing dual AAV vectors for (epi)genome editing and gene therapy. Nat Commun. 2023;14:6578.","journal-title":"Nat Commun"},{"key":"1430_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jim.2016.01.008","volume":"432","author":"M-LB Selenica","year":"2016","unstructured":"Selenica M-LB, Reid P, Pena G, Alvarez J, Hunt JB, Nash KR, et al. Adeno-associated viral-mediated intraosseus-labeling of bone marrow-derived cells for CNS tracking. J Immunol Methods. 2016;432:51\u201356.","journal-title":"J Immunol Methods"},{"key":"1430_CR29","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1136\/gutjnl-2022-327183","volume":"72","author":"H Lu","year":"2023","unstructured":"Lu H, Zhang C, Wu W, Chen H, Lin R, Sun R, et al. MCPIP1 restrains mucosal inflammation by orchestrating the intestinal monocyte to macrophage maturation via an ATF3-AP1S2 axis. Gut. 2023;72:882\u201395.","journal-title":"Gut"},{"key":"1430_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00612-x","volume":"12","author":"H Lu","year":"2024","unstructured":"Lu H, Suo Z, Lin J, Cong Y, Liu Z. Monocyte-macrophages modulate intestinal homeostasis in inflammatory bowel disease. Biomark Res. 2024;12:76.","journal-title":"Biomark Res"},{"key":"1430_CR31","doi-asserted-by":"publisher","first-page":"6806","DOI":"10.1158\/0008-5472.CAN-14-0160","volume":"74","author":"L Lapeire","year":"2014","unstructured":"Lapeire L, Hendrix A, Lambein K, Van Bockstal M, Braems G, Van Den Broecke R, et al. Cancer-associated adipose tissue promotes breast cancer progression by paracrine oncostatin M and Jak\/STAT3 signaling. Cancer Res. 2014;74:6806\u201319.","journal-title":"Cancer Res"},{"key":"1430_CR32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41586-021-03341-5","volume":"592","author":"TP Fidler","year":"2021","unstructured":"Fidler TP, Xue C, Yalcinkaya M, Hardaway B, Abramowicz S, Xiao T, et al. The AIM2 inflammasome exacerbates atherosclerosis in clonal hematopoiesis. Nature. 2021;592:296\u2013301.","journal-title":"Nature"},{"key":"1430_CR33","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.1128\/MCB.19.7.5106","volume":"19","author":"E Yang","year":"1999","unstructured":"Yang E, Wen Z, Haspel RL, Zhang JJ, Darnell JE. The linker domain of Stat1 is required for gamma interferon-driven transcription. Mol Cell Biol. 1999;19:5106\u201312.","journal-title":"Mol Cell Biol"},{"key":"1430_CR34","doi-asserted-by":"publisher","first-page":"13455","DOI":"10.1074\/jbc.M112038200","volume":"277","author":"E Yang","year":"2002","unstructured":"Yang E, Henriksen MA, Schaefer O, Zakharova N, Darnell JE. Dissociation time from DNA determines transcriptional function in a STAT1 linker mutant. J Biol Chem. 2002;277:13455\u201362.","journal-title":"J Biol Chem"},{"key":"1430_CR35","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41423-025-01266-x","volume":"22","author":"Y Zuo","year":"2025","unstructured":"Zuo Y, Wang Q, Tian W, Zheng Z, He W, Zhang R, et al. \u03b2-hydroxybutyrylation and O-GlcNAc modifications of STAT1 modulate antiviral defense in aging. Cell Mol Immunol. 2025;22:403\u201317.","journal-title":"Cell Mol Immunol"},{"key":"1430_CR36","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.cell.2025.01.043","volume":"188","author":"X He","year":"2025","unstructured":"He X, Wang Q, Cheng X, Wang W, Li Y, Nan Y, et al. Lysine vitcylation is a vitamin C-derived protein modification that enhances STAT1-mediated immune response. Cell. 2025;188:1858\u20131877.e21.","journal-title":"Cell"},{"key":"1430_CR37","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.cell.2017.06.042","volume":"170","author":"K Chen","year":"2017","unstructured":"Chen K, Liu J, Liu S, Xia M, Zhang X, Han D, et al. Methyltransferase SETD2-mediated methylation of STAT1 is critical for interferon antiviral activity. Cell. 2017;170:492\u2013506.e14.","journal-title":"Cell"},{"key":"1430_CR38","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/j.jaci.2017.07.027","volume":"141","author":"EP Sampaio","year":"2018","unstructured":"Sampaio EP, Ding L, Rose SR, Cruz P, Hsu AP, Kashyap A, et al. Novel signal transducer and activator of transcription 1 mutation disrupts small ubiquitin-related modifier conjugation, causing gain of function. J Allergy Clin Immunol. 2018;141:1844\u20131853.e2.","journal-title":"J Allergy Clin Immunol"},{"key":"1430_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14948-z","volume":"11","author":"Y Zuo","year":"2020","unstructured":"Zuo Y, Feng Q, Jin L, Huang F, Miao Y, Liu J, et al. Regulation of the linear ubiquitination of STAT1 controls antiviral interferon signaling. Nat Commun. 2020;11:1146.","journal-title":"Nat Commun"},{"key":"1430_CR40","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41418-020-00609-7","volume":"28","author":"X Guo","year":"2021","unstructured":"Guo X, Ma P, Li Y, Yang Y, Wang C, Xu T, et al. RNF220 mediates K63-linked polyubiquitination of STAT1 and promotes host defense. Cell Death Differ. 2021;28:640\u201356.","journal-title":"Cell Death Differ"},{"key":"1430_CR41","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41392-022-01057-0","volume":"7","author":"F Li","year":"2022","unstructured":"Li F, Liang H, You H, Xiao J, Xia H, Chen X, et al. Targeting the HECTD3-IKK\u03b1 axis inhibits inflammation-related metastasis. Signal Transduct Target Ther. 2022;7:264.","journal-title":"Signal Transduct Target Ther"},{"key":"1430_CR42","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1158\/1541-7786.MCR-13-0238","volume":"11","author":"DA Smith","year":"2013","unstructured":"Smith DA, Kiba A, Zong Y, Witte ON. Interleukin-6 and oncostatin-M synergize with the PI3K\/AKT pathway to promote aggressive prostate malignancy in mouse and human tissues. Mol Cancer Res. 2013;11:1159\u201365.","journal-title":"Mol Cancer Res"},{"key":"1430_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05208-9","volume":"12","author":"A Guo","year":"2022","unstructured":"Guo A, Ross C, Chande N, Gregor J, Ponich T, Khanna R, et al. High oncostatin M predicts lack of clinical remission for patients with inflammatory bowel disease on tumor necrosis factor \u03b1 antagonists. Sci Rep. 2022;12:1185.","journal-title":"Sci Rep"},{"key":"1430_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1239732","volume":"14","author":"CL Wolf","year":"2023","unstructured":"Wolf CL, Pruett C, Lighter D, Jorcyk CL. The clinical relevance of OSM in inflammatory diseases: a comprehensive review. Front Immunol. 2023;14:1239732.","journal-title":"Front Immunol"},{"key":"1430_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10859-w","volume":"10","author":"H Abe","year":"2019","unstructured":"Abe H, Takeda N, Isagawa T, Semba H, Nishimura S, Morioka MS, et al. Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M. Nat Commun. 2019;10:2824.","journal-title":"Nat Commun"},{"key":"1430_CR46","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1093\/nar\/27.23.4649","volume":"27","author":"Y Ma","year":"1999","unstructured":"Ma Y, Streiff RJ, Liu J, Spence MJ, Vestal RE. Cloning and characterization of human oncostatin M promoter. Nucleic Acids Res. 1999;27:4649\u201357.","journal-title":"Nucleic Acids Res"},{"key":"1430_CR47","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220525","volume":"220","author":"S Culemann","year":"2023","unstructured":"Culemann S, Knab K, Euler M, Wegner A, Garibagaoglu H, Ackermann J, et al. Stunning of neutrophils accounts for the anti-inflammatory effects of clodronate liposomes. J Exp Med. 2023;220:e20220525.","journal-title":"J Exp Med"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01430-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01430-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01430-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:23:00Z","timestamp":1782804180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01430-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":47,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["1430"],"URL":"https:\/\/doi.org\/10.1038\/s41423-026-01430-x","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}